News
Researchers from KU Leuven, the University of California Davis Medical Center, the University of Cologne, and over 20 ...
Fungal infections are getting harder to treat as they grow more resistant to available drugs, according to research published ...
Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...
Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results